Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah … [et al.]

Adjuvant trastuzumab has been used in human epidermal growth factor-2 (HER2) breast cancer to improve survival but with concern of cardiotoxicity. Our study is the first to review efficacy and toxicity of adjuvant trastuzumab in Malaysia. Methods: This is a retrospective cohort study on HER2 non met...

Full description

Bibliographic Details

Main Authors:	Hasbullah, Harissa H, Bustamam, Anita, Tho, Lye Munn, Phua, Vincent
Format:	Article
Language:	en
Published:	Universiti Teknologi MARA Cawangan Selangor 2018
Subjects:	RC Internal Medicine Neoplasms. Tumors. Oncology Cancer
Online Access:	https://ir.uitm.edu.my/id/eprint/30061/1/AJ_HARISSA%20H.%20ABDULLAH%20JCHC%20B%2018.pdf https://ir.uitm.edu.my/id/eprint/30061/ https://jchs-medicine.uitm.edu.my/index.php
Tags:	Add Tag No Tags, Be the first to tag this record!